A model of hypertension and proteinuria in cancer patients treated with the anti-angiogenic drug E7080

Author： Keizer Ron Gupta Anubha Mac Gillavry Melvin Jansen Mendel Wanders Jantien Beijnen Jos Schellens Jan Karlsson Mats Huitema Alwin

Publisher： Springer Publishing Company

ISSN： 1567-567X

Source： Journal of Pharmacokinetics and Pharmacodynamics, Vol.37, Iss.4, 2010-08, pp. : 347-363

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Rhinitis and epistaxis in patients treated by anti-angiogenic therapy

By Prulière-Escabasse V. Escudier E. Balheda R. Soria J. Coste A. Massard C.

Investigational New Drugs, Vol. 27, Iss. 3, 2009-06 ,pp. : 285-286

Springer Publishing Company

Access to resources Recommend Favorite

Anti-Angiogenic Therapies for Children with Cancer

Current Cancer Drug Targets, Vol. 10, Iss. 8, 2010-12 ,pp. : 879-889

Bentham Science Publishers

Access to resources Recommend Favorite

Target-based Anti-angiogenic Therapy in Breast Cancer

Current Pharmaceutical Design, Vol. 18, Iss. 27, 2012-09 ,pp. : 4244-4257

Bentham Science Publishers

Access to resources Recommend Favorite

Histone Deacetylases: Anti-Angiogenic Targets in Cancer Therapy

Current Cancer Drug Targets, Vol. 10, Iss. 8, 2010-12 ,pp. : 898-913

Bentham Science Publishers

Access to resources Recommend Favorite

Effect of Anti-hypertensive Drug Dose Frequency on the Clinic–Home Blood Pressure Difference in Patients with Stage 1 Treated Hypertension

By Huang H-C Lin M-S Kudo K Chang N-C Lee T-M

The Journal of International Medical Research, Vol. 33, Iss. 1, 2005-01 ,pp. : 111-118

Field House Publishing

Access to resources Recommend Favorite